Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Aptus Pharma Ltd

BSE: 544529 · Pharmaceuticals & Biotechnology · 26 announcements

Share price
₹385.20
Market cap
₹660.6 Cr
Revenue (annual)
₹46.57 Cr
Net profit (annual)
₹4.62 Cr
P/E (TTM)
143.0×Sector 47.4×
Promoter holding
72.89%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Buying (Off-Market) 4Fund Raise 3Board Meeting Outcome 3Other Announcement 2Financial Results 2Capital Structure Change 2Board Meeting Date 2Annual General Meeting 2Results Update 1Promoter Selling (Off-Market) 1Earnings Call 1Credit Rating 1Capacity Expansion 1Annual Report 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

2 announcements with these filters

18:06 IST BSE
Capital Structure Change

Aptus Pharma Capital Structure Change

Aptus Pharma approved a preferential issue of 16,02,870 equity shares at Rs. 280 per share, raising approximately Rs. 44.88 Crore. The board also scheduled the 16th AGM.

Value
₹44.88 Cr
Read the filing ↗
17:27 IST BSE
Capital Structure Change

Aptus Pharma Capital Structure Change

Aptus Pharma approved a preferential issue of 16,10,100 equity shares to various allottees. The company also fixed the Annual General Meeting date for September 14, 2026.

Read the filing ↗